
SINT Stock Forecast & Price Target
SINT Analyst Ratings
Bulls say
SINTX Technologies has demonstrated a strong potential for growth as indicated by a favorable NPV analysis, which suggests substantial upside from the current share price. The company's successful ramp-up in biomedical commercialization, alongside its recent acquisition, is expected to contribute positively to its financial performance. Additionally, the anticipated expansion of the global antimicrobial fertilizer and crop protection market, expected to reach $10 billion by 2030, provides additional opportunities for SINTX Technologies to enhance its market position and financial health.
Bears say
SINTX Technologies Inc reported a net loss of $2.3 million, translating to an earnings per share (EPS) of $(0.91), which was below previous estimates of $(0.79). Additionally, the company faces considerable risks that could impact its financial stability, including balance sheet and liquidity challenges, potential failures in demonstrating the safety and efficacy of its product candidates, and difficulties in securing regulatory approvals and reimbursement. These risks, coupled with the competitive landscape and shifting macroeconomic conditions, contribute to a cautious outlook regarding the company's financial performance and stock potential.
This aggregate rating is based on analysts' research of SINTX Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
SINT Analyst Forecast & Price Prediction
Start investing in SINT
Order type
Buy in
Order amount
Est. shares
0 shares